http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
이관주,정재희,홍민광,원용성,안창혁,송영택,Lee, Kwan-Ju,Chung, Jae-Hee,Hong, Min-Kwang,Won, Yong-Sung,An, Chang-Hyeok,Song, Young-Tack 대한소아외과학회 2001 소아외과 Vol.7 No.2
Childhood intussusception is usually idiopathic, and pathological lesions as the leading point are found in limited cases. Sixteen operative cases with leadpoints among 2,889 cases of childhood intussusecption treated at the surgical departments of the affiliated hospitals of Catholic University over 19 years are reviewed. The approximate incidence of pathological lesions as the leading point was 0.6%. The male to female ratio was 2:1. The mean age was 3.5 years. There was not an age preponderance. The symptoms were vomiting(63%), abdominal pain(38%), irritability(38%), bloody stools(25%), fever(25%) and abdominal mass(6%). The average duration of the symptoms was 2.4 days(1-10days). The most common lesion was Meckel's diverticulum, followed by malignant lymphomas, polyps, ectopic pancreas, and cecal duplication. An ileocolic type was most frequent, followed by ileoileocolic and ileoileal. Segmental resection or wedge resection of the ileum was done in 10 cases, ileocecectomy in 3, and right hemicolectomy in 3. Surgical reduction was done only in an ectopic pancreas, with no later recurrence. The average hospital stay was 10 days. Postoperative adhesive ileus occurred in two cases, and in one of them adhesiolysis was performed. One case of malignant lymphoma died at 28 days after surgery due to chemotherapy related complication.
하지 Buerger씨 병에서 Prostaglandin E₁경구투여제 Opalmon(OP-1206-α-CD)의 임상경험
김인철,박장상,고용복,홍민광 대한혈관외과학회 1993 Vascular Specialist International Vol.9 No.1
Most of Buerger's disease is not amenable to rcconstructive arterial surgery and many conservative therapies are introduced. If these measures fail to provide adenquate relief. A major amputation will be required to escape from the intractable rest pain. It has been noted that prostaglandin E₁(PGE₁) has a prominent vasodilating activity as well as an inhibitory effect on platelet aggregation and PGE₁ is used widely as a conservative therapy for the patients with chronic arterial occlusive disease surch as Buerger's disease. However, PGE₁, is administered parenterally by arterial or venous route and can not be used by route because it is inactivated by l5-OH-prostaglandin dehydrogenase in G-I tract. Recently oral PGE₁ derivative, Opalmon(OP-l206-α-CD), is developed, and it has been known that it is hardly inactivated in G-I tract and selectively dilates blood vessels and inhibits platelet aggregation like PGE₁. The authors obtained Opalmon(OP-1206-α-CD) from Ono Pharmaceutical Co(Japan) and applied to 30 patients of Buergers disease of lower extremities. They had disabled claudications or rest pain with ischemic ulcers or gangrenes. Ulcers or gangrenes on distal limbs were measured by ruler and color photographs were taken once a week. Arteriograms were performed in all patients before Opalmon administration. Opalmon 10μg was administered orally 3 times after each meal(30μg/day) every day for 6 weeks. ] All patients were followed up for 2 months∼6 months. The observed results were as follows. 1) Fontaine classifications before Opalmon treatment were stage II; 12 patients, Stage III; 2 patients and Stage IV; 16 patients. Fontaine classifications after Opalmon treatment were stage I; 17 patients, stage II; 7 patients, stage III; 1 patient and stage IV; 5 patients. 2) Beneficial effect of Opalmon was significant in patients whose arteriogram showed good distal collateral development. 3) Improvement rate was more prominent in patients who had the hisotry of PGE₁ infusion therapy previously. 4) Side effects were mild transient abdominal pain, diarrhea, nausea and vomiting which were complained in only 2 patients. 5) Overall improvement gradings were classified as $quot;markedly improved$quot; in 7 patients(23.3 %), $quot;improved$quot; in 1l patients(36.7%), $quot;slightly improved$quot; in l patient(3.3%), $quot;unchanged$quot; in 8 patients(26.7%) and $quot;aggravated$quot; in 3 patients(10.0%) who required eventual B-K amputation. Overall improvement rate was counted 63.3%. In summary of this clinical observation, it can be considered that Opalmon(OP-1206-α-CD) is an effective agent for the treatment of Buerger's disease of lower extremities, although this study was done in limited numbers of patients and not double blinded.$quot;
이근호,최승혜,고용복,홍민광 대한혈관외과학회 1992 Vascular Specialist International Vol.8 No.1
Budd-Chiari syndrome is an unusual form of portal hypertension caused by occlusion of the hepatic venous outflow and it is often frequently complicated by inferior vena caval occlusion. Its prognosis is poor and optimal therapy remains to be established. 15 patients with the Budd- Chiari syndrome were treated surgically at Catholic University Medial College. Nine of the patients were male and six were female. The largest number of patients, Five were in their thirties. Four patients(27%) had membranous obstruction of vena cava, but in other eleven patients(73%) no etiologic factors or associated disorders were identified. Ascites and hepa- tomegaly were the most common presenting feature in this group of patients. Hepatic function at time of diagnosis, as measured by standard serum chemistries, was only minimally abnormal. The diagnosis of the Budd-Chiari syndrome was confirmed in all fifteen patients by vena cavography with hepatic vein catheterization and revealed caval occlusion in fourteen patients. Interpretation of the vena cavogram was helpful in selecting the appropriate surgical procedure for each patients. In eight patients, a transcaval thrombectomy was performed with one intraoperative death(12.5%) by bleeding. Finger fracture technique was performed in four patients of membranous obstruction of vena cava and mesocaval shunt in one patient of hepatic vein occlusion with no operative mortality. Mesoatrial shunt was performed in two patients and one of them was died of postoperative bleeding at 9th. Postoperative day. Overall operative mortality was 13%(2/15). Remaining thirteen patients in this series were discharged hospital alive and well.